Unresectable, no known HER2 positive status, locally advanced or metastatic G/GEJ adenocarcinoma. 74.3% male, 36.1% with age ≥ 65 years, 27.7% ECOG 0, all patients were from China. Here, ERBB2 is linked to gastroesophageal junction adenocarcinoma.